Leilei Tang

463 total citations
20 papers, 336 citations indexed

About

Leilei Tang is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Leilei Tang has authored 20 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Leilei Tang's work include Per- and polyfluoroalkyl substances research (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Microbial metabolism and enzyme function (3 papers). Leilei Tang is often cited by papers focused on Per- and polyfluoroalkyl substances research (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Microbial metabolism and enzyme function (3 papers). Leilei Tang collaborates with scholars based in China, Switzerland and United States. Leilei Tang's co-authors include Danyan Zhu, Ren‐Shan Ge, Lingdi Zhang, Bei Zheng, Zhe Zhao, Andreas Zeller, Tingting Xu, Jiajie Zheng, Yiyang Dai and Melanie Guérard and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Leilei Tang

20 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leilei Tang China 12 161 86 78 57 42 20 336
Yuefeng He China 12 208 1.3× 106 1.2× 45 0.6× 38 0.7× 31 0.7× 38 361
Weiping Xu China 10 120 0.7× 52 0.6× 63 0.8× 44 0.8× 75 1.8× 22 362
Chong Wan China 8 138 0.9× 52 0.6× 111 1.4× 93 1.6× 14 0.3× 15 317
Shuai Ben China 13 232 1.4× 140 1.6× 41 0.5× 94 1.6× 28 0.7× 41 523
Long Cui China 11 135 0.8× 81 0.9× 33 0.4× 36 0.6× 42 1.0× 23 378
Dhiral Phadke United States 10 295 1.8× 78 0.9× 60 0.8× 51 0.9× 72 1.7× 25 473
Chandni Valiathan United States 8 124 0.8× 46 0.5× 109 1.4× 147 2.6× 25 0.6× 13 351
Boqun Xu China 14 319 2.0× 148 1.7× 27 0.3× 24 0.4× 88 2.1× 29 591
Kejia Wu China 12 233 1.4× 160 1.9× 35 0.4× 25 0.4× 44 1.0× 20 384
Xinhua Zhu China 7 280 1.7× 54 0.6× 43 0.6× 13 0.2× 33 0.8× 10 372

Countries citing papers authored by Leilei Tang

Since Specialization
Citations

This map shows the geographic impact of Leilei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilei Tang more than expected).

Fields of papers citing papers by Leilei Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leilei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilei Tang. The network helps show where Leilei Tang may publish in the future.

Co-authorship network of co-authors of Leilei Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Leilei Tang. A scholar is included among the top collaborators of Leilei Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leilei Tang. Leilei Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tang, Leilei, et al.. (2023). The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway. Cellular and Molecular Neurobiology. 43(8). 4261–4277. 2 indexed citations
3.
Tang, Leilei, et al.. (2023). Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166984–166984. 57 indexed citations
4.
Tang, Leilei, et al.. (2023). Pulmonary infection is associated with an increased IL-6 in acute exacerbation chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 21. 2 indexed citations
5.
Tang, Leilei, et al.. (2022). Oxidative stress and Cx43-mediated apoptosis are involved in PFOS-induced nephrotoxicity. Toxicology. 478. 153283–153283. 19 indexed citations
6.
Xu, Dongmin, et al.. (2021). Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats. Experimental and Therapeutic Medicine. 23(1). 14–14. 21 indexed citations
7.
Wang, Yu, et al.. (2021). Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase. Molecular Medicine Reports. 23(4). 12 indexed citations
8.
Zheng, Bei, et al.. (2017). mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells. The International Journal of Developmental Biology. 61(1-2). 65–72. 12 indexed citations
9.
Zheng, Bei, Leilei Tang, Chao Tan, et al.. (2017). Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells in vitro. International Journal of Biological Sciences. 13(1). 110–121. 12 indexed citations
10.
Tang, Leilei, Tingting Xu, Zhe Zhao, et al.. (2017). Mitochondrial toxicity of perfluorooctane sulfonate in mouse embryonic stem cell-derived cardiomyocytes. Toxicology. 382. 108–116. 47 indexed citations
11.
Tang, Leilei, et al.. (2017). Identification and Characterization of Lipopolysaccharide Induced TNFα Factor from Blunt Snout Bream, Megalobrama amblycephala. International Journal of Molecular Sciences. 18(2). 233–233. 7 indexed citations
12.
Tang, Leilei, et al.. (2016). Identification and characterization of immune-related microRNAs in blunt snout bream, Megalobrama amblycephala. Fish & Shellfish Immunology. 49. 470–492. 36 indexed citations
13.
Sun, Ping, Ling Ma, Rong Xia, et al.. (2015). Prevalence of hepatitis A viral RNA and antibodies among Chinese blood donors. Genetics and Molecular Research. 14(4). 16431–16437. 2 indexed citations
14.
Zeller, Andreas, Leilei Tang, Stephen D. Dertinger, et al.. (2015). A proposal for a novel rationale for critical effect size in dose–response analysis based on a multi-endpointin vivostudy with methyl methanesulfonate. Mutagenesis. 31(3). 239–253. 17 indexed citations
15.
Yang, Sheng‐Shun, et al.. (2015). Efficacy of drug-eluting stent for chronic total coronary occlusions at different follow-up duration: a systematic review and meta-analysis.. PubMed. 19(6). 1101–16. 8 indexed citations
16.
Zhang, Yingying, Leilei Tang, Bei Zheng, Ren‐Shan Ge, & Danyan Zhu. (2015). Protein profiles of cardiomyocyte differentiation in murine embryonic stem cells exposed to perfluorooctane sulfonate. Journal of Applied Toxicology. 36(5). 726–740. 21 indexed citations
17.
Zhou, Limin, Bei Zheng, Leilei Tang, Yujie Huang, & Danyan Zhu. (2014). Involvement of PIKE in icariin induced cardiomyocyte differentiation from murine embryonic stem cells.. PubMed. 69(3). 198–202. 6 indexed citations
18.
Tang, Leilei, Melanie Guérard, & Andreas Zeller. (2013). Quantitative assessment of the dose–response of alkylating agents in DNA repair proficient and deficient ames tester strains. Environmental and Molecular Mutagenesis. 55(1). 15–23. 11 indexed citations
19.
Gocke, Elmar, Leilei Tang, & Thomas P. Singer. (2012). Exposure to Ethylating Agents: Where Do the Thresholds for Mutagenic/Clastogenic Effects Arise?. Genes and Environment. 34(4). 171–178. 3 indexed citations
20.
Tang, Leilei, Saskia M. Bergevoet, Christian Gilissen, et al.. (2010). Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells. BMC Pharmacology. 10(1). 12–12. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuefeng He Breakdown of academic impact, for papers by Weiping Xu Breakdown of academic impact, for papers by Chong Wan Breakdown of academic impact, for papers by Shuai Ben Breakdown of academic impact, for papers by Long Cui Breakdown of academic impact, for papers by Dhiral Phadke Breakdown of academic impact, for papers by Chandni Valiathan Breakdown of academic impact, for papers by Boqun Xu Breakdown of academic impact, for papers by Kejia Wu Breakdown of academic impact, for papers by Xinhua Zhu
Rankless by CCL
2026